-
- Janine Warren
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA
-
- Yuxuan Xiao
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA
-
- John Lamar
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA
書誌事項
- 公開日
- 2018-04-10
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.3390/cancers10040115
- 公開者
- MDPI AG
説明
<jats:p>Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both emerged as important drivers of cancer progression and metastasis. YAP and TAZ are often upregulated or nuclear localized in aggressive human cancers. There is abundant experimental evidence demonstrating that YAP or TAZ activation promotes cancer formation, tumor progression, and metastasis. In this review we summarize the evidence linking YAP/TAZ activation to metastasis, and discuss the roles of YAP and TAZ during each step of the metastatic cascade. Collectively, this evidence strongly suggests that inappropriate YAP or TAZ activity plays a causal role in cancer, and that targeting aberrant YAP/TAZ activation is a promising strategy for the treatment of metastatic disease. To this end, we also discuss several potential strategies for inhibiting YAP/TAZ activation in cancer and the challenges each strategy poses.</jats:p>
収録刊行物
-
- Cancers
-
Cancers 10 (4), 115-, 2018-04-10
MDPI AG
